Earnings History Data for Galera Therapeutics, Inc. (GRTX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Galera Therapeutics, Inc.

Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel, proprietary therapeutics to transform radiotherapy in cancer. The company's product candidate is GC4419, a highly selective and potent small molecule dismutase mimetic which is designed to rapidly convert superoxide to hydrogen peroxide. Galera Therapeutics, Inc. is headquartered in Malvern, PA.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
14-11-2023 PM GRTX Galera Therapeutics 5.00 -0.33 -0.44 0.00 Galera Therapeutics GAAP EPS of -$0.33
[11/14/2023 8:51 AM]
0.1386 0.0 
(1.84%)
0.15 0.01 
(10.14%)
0.09 - 3.59 1,587,726 7,960,000 321,693
14-08-2023 PM GRTX Galera Therapeutics 15.00 -0.48 -0.43 0.00 Galera Therapeutics GAAP EPS of -$0.48
[8/14/2023 9:48 AM]
0.2983 -0.02 
(-7.42%)
0.32 -0.01 
(-1.92%)
0.29 - 3.59 6,704,811 8,310,000 763,542
11-05-2023 PM GRTX Galera Therapeutics 140.00 -0.50 -0.36 0.00 Galera Therapeutics GAAP EPS of -$0.50 misses by $0.09
[5/11/2023 9:43 AM]
3.10 -0.06 
(-2.05%)
3.14 -0.03 
(-0.95%)
1.12 - 3.50 614,632 810,000 9,229
08-03-2023 PM 7:00 AM ET
(Mar 8)
GRTX Galera Therapeutics 52.00 -0.58 -0.50 0.00 Galera Therapeutics GAAP EPS of -$0.58 misses by $0.06
[3/8/2023 7:48 AM]
1.83 0.01 
(0.55%)
1.83 0.01 
(0.55%)
1.12 - 2.75 1,530,877 540,000 136
16-05-2022 PM GRTX Galera Therapeutics 33.00 -0.58 -0.53 0.00 Galera Therapeutics GAAP EPS of -$0.58
[5/16/2022 9:04 AM]
1.70 0.19 
(12.58%)
1.58 0.07 
(4.64%)
1.15 - 10.79 460,245 230,000 31,974
10-11-2021 PM GRTX Galera Therapeutics, Inc. 51.68 -0.86 -0.65 -0.69 Galera Therapeutics EPS misses by $0.15
[11/10/2021 8:57 AM]
1.74 -0.08 
(-4.67%)
1.75 -0.07 
(-3.85%)
1.63 - 12.99 1,320,392 11,370,000 270,042
10-08-2021 PM GRTX Galera Therapeutics, Inc. 211.63 -0.88 -0.79 -0.75 Galera Therapeutics EPS misses by $0.06
[8/10/2021 8:33 AM]
8.66 0.09 
(1.05%)
9.00 0.43 
(5.02%)
5.87 - 15.00 55,886 70,000 425
11-05-2021 PM 7:00 AM ET
(May 11)
GRTX Galera Therapeutics, Inc. 153.55 -0.75 -0.81 -0.74 Galera Therapeutics EPS beats by $0.06
[5/11/2021 7:51 AM]
6.97 0.50 
(7.73%)
6.01 -0.46 
(-7.15%)
5.87 - 15.00 346,981 3,150,000 2,665
11-03-2021 PM GRTX Galera Therapeutics, Inc. 268.00 -0.80 -0.66 0.00 Galera Therapeutics reports Q4 results
[3/11/2021 7:43 AM]
11.21 0.18 
(1.63%)
11.03 0.0 
(0.00%)
5.58 - 15.00 17,163 31,269 225
10-11-2020 PM GRTX Galera Therapeutics, Inc. 254.00 -0.69 -0.77 0.00 Galera Therapeutics EPS beats by $0.08
[11/10/2020 7:21 AM]
10.56 0.18 
(1.78%)
0.0 0.0 
(0.00%)
5.58 - 19.50 17,795 94,829 0
10-08-2020 PM GRTX Galera Therapeutics, Inc. 197.60 -0.75 -0.75 0.00 Galera Therapeutics EPS beats by $0.01
[8/10/2020 7:09 AM]
7.94 0.13 
(1.66%)
7.96 0.0 
(0.00%)
5.58 - 19.50 2,312 24,099 207